Tirzepatide

Tirzepatide is a metabolic-focused research peptide developed for investigative research into dual receptor signaling and integrated metabolic communication pathways. Tirzepatide is a once-weekly injectable medication that mimics two natural gut hormones—GLP-1 and GIP—to manage blood sugar, reduce appetite and slow digestion. . It is sold under the brand names Mounjaro for type 2 diabetes and Zepbound for chronic weight management and obstructive sleep apnea.

Research Applications:

• Tells your pancreas to produce more insulin when your blood sugar levels are high, typically after eating
• Reduces the amount of sugar (glucose) released into the bloodstream by your liver
• Acts on specific receptors in the brain to regulate appetite, reduce food cravings, and increase feelings of satiety
• Delays how fast food leaves your stomach (gastric emptying), which helps keep post-meal blood sugar steady
• Targets areas of the brain that regulate appetite and promote feelings of fullness